The second iteration of the Biomedical HIV Prevention Summit will be held December 4-5, 2017 in New Orleans, Louisiana. We have changed the summit’s name from the National HIV PrEP Summit to the Biomedical HIV Prevention Summit (The Summit). NMAC believes the new name allows us to think about the expanded integrated role that PrEP, PEP and Treatment as Prevention (TasP) play in building the pathways to ending the epidemic
The conference’s logo represents a collaboration between community-based organizations (CBOs), health departments (HDs), national organizations and NMAC. This meeting brings together HIV leaders to discuss and learn about PrEP, PEP, TasP, and other biomedical HIV prevention interventions.
NMAC thanks Gilead for recommitting their support of this meeting. The conversations will focus on the implementation and infrastructure needed to turn the promise of the science into an effective community-level HIV prevention option for community most in need.